Thymosin β4 and corneal wound healing: Visions of the future

Annals of the New York Academy of Sciences

Volumn 1194, Issue , 2010, Pages 190-198

  Sosne, Gabriel ^a   Qiu, Ping ^a   Kurpakus Wheater, Michelle ^b   Matthew, Howard ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DETROIT MERCY   (United States)

^c Wayne State University   (United States)

Author keywords

Cell migration; Cornea; Inflammation; Thymosin 4; Wound healing

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; THYMOSIN BETA4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; CORTICOSTEROID; THYMOSIN; THYMOSIN BETA(4);

ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CORNEA INJURY; CYTOKINE RELEASE; HUMAN; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; CORNEA; CORNEA DISEASE; DRUG EFFECT; EYE INJURY; FORECASTING; INFLAMMATION; INJURY; MOUSE; PHYSIOLOGY; REVIEW;

ADRENAL CORTEX HORMONES; ANIMALS; CORNEA; CORNEAL DISEASES; EYE INJURIES; FORECASTING; INFLAMMATION; MICE; THYMOSIN; WOUND HEALING;

EID: 77951845671     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05472.x     Document Type: Conference Paper

References (52)

1. Sosne, G., C.C. Chan, K. Thai, et al. 2001. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 72: 605-608.
2. Sosne, G., E.A. Szliter, R. Barrett, et al. 2002. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp. Eye Res. 74: 293-299.
3. SosneG., A. Siddiqi&M.Kurpakus-Wheater. 2004. Thymosin beta-4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest.Ophthalmol. Vis. Sci. 45: 1095-1100.
4. Sosne, G., P. Qiu, P.L. Christopherson & M.K. Wheater. 2007. Thymosin beta 4 suppression of corneal NFkappaB: A potential anti-inflammatory pathway. Exp. Eye Res. 84: 663-669.
5. Gillitzer, R. & M. Goebeler. 2001. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69: 513-521.
6. Wilson, S.E., M. Netto & R. Ambrosio Jr. 2003. Corneal cells: Chatty in development, homeostasis, wound healing, and disease. Am. J. Ophthalmol. 136: 530-536.
7. Agrawal, V.B.& R.J. Tsai. 2003. Corneal epithelial wound healing. Indian J. Ophthalmol. 51: 5-15.
8. Stramer, B.M., J.S. Austin, A.B. Roberts & M.E. Fini. 2004. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3. J. Cell. Physiol. 203: 226-232.
9. Planck, S.R., L.F. Rich, J.C. Ansel, et al. 1997. Trauma and alkali burns induce distinct patterns of cytokine gene expression in the rat cornea. Ocul. Immunol. Inflamm. 5: 95-100.
10. Sotozono, C., J. He, Y.Matsumoto, et al. 1997. Cytokine expression in the alkali-burned cornea. Curr. Eye Res. 16: 670-676.
11. Luo, L., D.Q. Li, A. Doshi, et al. 2004. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest. Ophthalmol. Vis. Sci. 45: 4293-4301.
12. Zhang, J., X.Y. Wu & F.S. Yu. 2005. Inflammatory responses of corneal epithelial cells to Pseudomonas aeruginosa infection. Curr. Eye Res. 30: 527-534.
13. Zhang, S., Z.N. Lin, C.F. Yang, et al. 2004. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alphainduced apoptosis in human cancer cells. Carcinogenesis 25: 2191-2199.
14. Baud, V.&M. Karin. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell. Biol. 11: 372-377.
15. Hanada,T.& A. Yoshimura. 2002.Regulation of cytokine signaling and inflammation.CytokineGrowth Factor Rev. 13: 413-421.
16. Ritchie, M.H., R.A. Fillmore, R.N. Lausch & J.E. Oakes. 2004. A role for NF-kappa B binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 45: 2299-2305.
17. Karin, M.& Y. Ben-Neriah. 2000. Phosphorylationmeets ubiquitination: The control ofNF-kappaB activity. Annu. Rev. Immunol. 18: 621-663.
18. Hayden,M.S.& S. Ghosh. 2004. Signaling toNF-kappaB. Genes Dev. 18: 2195-2224.
19. Legler, D.F., O. Micheau, M.A. Doucey, et al. 2003. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18: 655-664.
20. Grzybek, M., A. Kozubek, P. Dubielecka & A.F. Sikorski. 2005. Rafts-the current picture. Folia. Histochem. Cytobiol. 43: 3-10.
21. Helms, J.B. & C. Zurzolo. 2004. Lipids as targeting signals: Lipid rafts and intracellular trafficking. Traffic 5: 247-254.
22. Yamamoto, N., N. Yamamoto, M.W. Petroll, et al. 2005. Internalization of Pseudomonas aeruginosa is mediated by lipid rafts in contact lens-wearing rabbit and cultured human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 46: 1348-1355.
23. Yamamoto, N., N. Yamamoto, J.V. Jester, et al. 2006. Prolonged hypoxia induces lipid raft formation and increases Pseudomonas internalization in vivo after contact lens wear and lid closure. Eye Contact Lens 32: 114-120.
24. MacLellan, D.L., H. Steen, R.M. Adam, et al. 2005. A quantitative proteomic analysis of growth factorinduced compositional changes in lipid rafts of human smooth muscle cells. Proteomics 5: 4733-4742.
25. Jolly, C., I.Mitar & Q.J. Sattentau. 2007. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J. Virol. 81: 5547-5560.
26. Bodin, S., C. Soulet, H. Tronchere, et al. 2005. Integrindependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. J. Cell Sci. 118: 759-769.
27. Head, B.P., H.H. Patel, D.M. Roth, et al. 2006. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J. Biol. Chem. 281: 26391-26399.
28. Li, J., Q. Li, C. Xie, et al. 2004. Beta-actin is required for mitochondria clustering and ROS generation in TNFinduced, caspase-independent cell death. J. Cell Sci. 117: 4673-4680.
29. Morley, S.C., J. Sung, G.P. Sun, et al. 2007. Gelsolin overexpression alters actin dynamics and tyrosine phosphorylation of lipid raft-associated proteins in Jurkat T cells. Mol. Immunol. 44: 2469-2480.
30. Pahl, H.L. 1999. Activators and target genes of Rel/NFkappaB transcription factors. Oncogene 18: 6853-6866.
31. Mohan, R., W.B. Rinehart, P. Bargagna-Mohan & M.E. Fini. 1998. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinaseBexpression during developmental and injury-related tissue remodeling. J. Biol. Chem. 273: 25903-25914.
32. Perkins, N.D. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell. Biol. 8: 49-62.
33. Karin, M. & M. Delhase. 2000. The I kappa B kinase (IKK) and NF-kappa B: Key elements of proinflammatory signalling. Semin. Immunol. 12: 85-98.
34. Kaufman, H.E., E.D. Ellison & W.M. Townsend. 1970. The chemotherapy of herpes iritis with adenine arabinoside and cytarabine. Arch. Ophthalmol. 84: 783-787.
35. Aquavella, J.V. 1973. The soft contact lens. I. Therapeutic experience with the Softcon lens. Int. Ophthalmol. Clin. 13: 167-177.
36. Matoba, A.Y. & J.P. McCulley. 1985. The effect of therapeutic soft contact lenses on antibiotic delivery to the cornea. Ophthalmology 92: 97-99.
37. Aquavella, J.V. 1976. New aspects of contact lenses in ophthalmology. Adv. Ophthalmol. 32: 2-34.
38. Dreifus, M., O.Wichterle & D. Lim. 1960. Intra-cameral lenses made of hydrocolloidal acrylates. Cesk. Oftalmol. 16: 154-159.
39. Machat, J. 1996. Excimer Laser Refractive Surgery Practice and Principles. SLACK. New Jersey.
40. Podos, S.M., B. Becker, C. Asseff & J. Hartstein. 1972. Pilocarpine therapy with soft contact lenses.Am. J. Ophthalmol. 73: 336-341.
41. Langston, R.H., C.J. Machamer & C.W. Norman. 1978. Soft lens therapy for recurrent erosion syndrome. Ann. Ophthalmol. 10: 875-878.
42. Leibowitz, H.M. & P. Rosenthal. 1971. Hydrophilic contact lenses in corneal disease.Part II.Bullous keratopathy. Arch. Ophthalmol. 85: 283-285.
43. Peppas, N.A., K.B. Keys, M. Torres-Lugo & A.M. Lowman. 1999. Poly(ethylene glycol)-containing hydrogels in drug delivery. J. Control. Release 62: 81-87.
44. Elbert, D.L., A.B. Pratt, M.P. Lutolf, et al. 2001. Protein delivery from materials formed by self-selective conjugate addition reactions. J. Controlled Release 76: 11-25.
45. Anseth, K.S., A.T. Metters, S.J. Bryant, et al. 2002. In situ forming degradable networks and their application in tissue engineering and drug delivery. J. Controlled Release 78: 199-209.
46. Burdick, J.A., M.N. Mason, A.D. Hinman, et al. 2002. Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. J. Controlled Release 83: 53-63.
47. Ichikawa, H. & N.A. Peppas. 2003. Novel complexation hydrogels for oral peptide delivery: In vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers. J. Biomed. Mater. Res. A 67: 609-617.
48. Andreopoulos, F.M. & I. Persaud. 2006. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. Biomaterials 27: 2468-2476.
49. Kumar, A., S.S. Lahiri & H. Singh. 2006. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery. Int. J. Pharm. 323: 117-124.
50. Livnat, M., R. Beyar & D. Seliktar. 2005. Endoluminal hydrogel films made of alginate and polyethylene glycol: Physical characteristics and drug-eluting properties. J. Biomed. Mater. Res. A 75: 710-722.
51. Coviello, T., P.Matricardi & F. Alhaique. 2006. Drug delivery strategies using polysaccharidic gels. Expert Opin. Drug Deliv. 3: 395-404.
52. Liu, W., M. Griffith & F. Li 2008. Alginate microspherecollagen composite hydrogel for ocular drug delivery and implantation. J. Mater. Sci. Mater. Med. 19: 3365-3371.